Novartis registers new Phase IIIb IgAN trial and VEXAS Phase 2; gMG trial still activeSep 30Weekly roundup, 7 itemsarumakimigatrasentanUpdated
Novartis registers Phase 2 VEXAS trial for arumakimig; posts MS treatment-pattern study resultsAug 6Weekly roundup, 2 itemsarumakimigNovartis
Sign inSign in